A gonadotrophin-based fertility medication containing highly purified human menopausal gonadotrophin (hMG). It is used to stimulate ovarian follicle growth in women undergoing fertility treatment and to promote sperm production in men with specific hormonal deficiencies.

Indications:
- Treatment of women with anovulation (including polycystic ovary syndrome) unresponsive to clomiphene citrate.
- Controlled ovarian hyperstimulation in assisted reproductive techniques (e.g., IVF, ICSI).
- Induction of spermatogenesis in men with hypogonadotropic hypogonadism, usually in combination with hCG.

Main Active Ingredient:
- Human Menopausal Gonadotrophin (hMG).

Precautions:
- To be prescribed and monitored only by fertility specialists.
- Increased risk of Ovarian Hyperstimulation Syndrome (OHSS), particularly in women with PCOS.
- Risk of multiple pregnancy if not properly monitored.
- Contraindicated in women with ovarian, uterine, breast, or testicular tumors.
- Contraindicated in cases of unexplained vaginal bleeding, ovarian cysts not related to PCOS, or primary ovarian/testicular failure.
- Caution in patients with history of thromboembolic disorders, severe uncontrolled thyroid/adrenal dysfunction.

Side Effects:
- Injection site pain/reaction
- Headache.
- Abdominal discomfort.
- bloating.
- Nausea.
- Pelvic pain.
- Breast tenderness.
- Mild/moderate OHSS.
- Severe OHSS.
- Blood clots.
- Allergic reactions.

Drug-Drug Interactions:
- Other fertility drugs.
- GnRH agonists/antagonists.
- Hormone-related drugs.